.svg)
About
Teva Pharmaceuticals and Medincell are committed to advancing healthcare through innovation in drug delivery technologies. Their collaboration focuses on developing long-acting treatments that improve patient outcomes and enhance quality of life. Together, they harness cutting-edge research and insights from the healthcare community to bring effective solutions to patients worldwide.
The Challenge
Teva Pharmaceuticals, in collaboration with Medincell, sought to bring a groundbreaking long-acting injectable treatment to market. The objective was not only to build a robust marketing campaign but also to ensure the R&D pipeline's viability through strategic insights. With the stakes high, the project required deep engagement with key opinion leaders (KOLs) in the healthcare field and a thorough analysis of real-world data from industry congresses and market trends. The challenge was to validate the ongoing clinical trials, fine-tune the development strategy, and effectively position the product for launch.
Our Approach
Our team embarked on a comprehensive campaign, starting with identifying and interviewing global KOLs in relevant therapeutic areas. This process provided valuable insights into the unmet needs within the field, allowing us to better align the product’s development with market demands. Additionally, we attended key healthcare congresses to gather the latest trends and competitor information, using these insights to inform our strategy. By synthesizing this information with market data, we were able to provide actionable recommendations to Teva and Medincell regarding the future of their R&D pipeline. As we moved toward the final phase, our focus shifted to developing a targeted marketing strategy for the product launch. This involved creating educational materials, digital campaigns, and outreach initiatives that emphasized the unique benefits of the injectable treatment. We ensured that the messaging was not only scientifically accurate but also accessible and engaging for both healthcare professionals and patients.
Execution
We worked closely with Teva and Medincell’s internal teams to ensure seamless execution across all phases. The initial stages included structured interviews and focus groups with KOLs, during which we identified critical product differentiators and gathered insights on potential challenges. These insights were further refined through data gathered at international healthcare congresses, enabling us to develop a strong narrative around the product’s value proposition. For the marketing campaign, we crafted targeted content that highlighted the treatment's innovative delivery method and its advantages over existing therapies. Through a combination of digital ads, educational content, and outreach to healthcare providers, we positioned the product as a key player in the long-acting treatment space. The campaign was strategically launched across multiple platforms, reaching a broad audience and ensuring the product’s benefits were clearly communicated.
The Results
The campaign’s success was underscored by strong engagement from both healthcare providers and patients. KOLs expressed high levels of interest, with several highlighting the product's potential to address significant gaps in treatment adherence. The insights we provided helped Teva and Medincell make informed decisions about their clinical trials, leading to continued investment in the R&D pipeline. Post-launch, the product achieved impressive market traction, solidifying its position in the industry as a valuable treatment option. This project not only validated the importance of strategic market insights but also showcased the impact of a well-executed, data-driven marketing campaign.
.webp)
.webp)
.svg)
